ArticleThe journal of allergy and clinical immunology. Global2025

Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa.

Thomas Leeuw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.